Publication | Closed Access

The impact on coagulation of an intravenous loading dose in addition to a subcutaneousregimen of low-molecular-weight heparinin the initial treatment of acute coronary syndromes

ThrombosisCardiovascular DiseaseBlood PlateletInitial TreatmentLow-molecular-weight HeparininMedicineCardiologyPharmacotherapyCoagulopathyPublic HealthPlatelet AntagonistPharmacologyAnticoagulantAtherosclerosisAcute Coronary SyndromesHeparinsAcute Myocardial Infarction